IB-367, a Protegrin Peptide with In Vitro and In Vivo Activities against the Microflora Associated with Oral Mucositis - Mosca, Deborah A.; Hurst, Malinda A.; So, Wendy; Viajar, Beverly S. C.; Fujii, Craig A.; Falla, Timothy J. (Antimicrobial Agents and Chemotherapy, 2000)
Keywords: Anti-Bacterial Agents; Anti-Bacterial Agents - pharmacology; Anti-Bacterial Agents - therapeutic use; Antibacterial agents; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antimicrobial Cationic Peptides; Biological and medical sciences; Drug Resistance, Microbial - physiology; Escherichia; Escherichia - drug effects; Escherichia - physiology; Humans; Klebsiella; Klebsiella - drug effects; Klebsiella - physiology; Medical sciences; Microbial Sensitivity Tests; Mouth Diseases; Mouth Diseases - drug therapy; Mouth Diseases - microbiology; Mouth Mucosa - drug effects; Mouth Mucosa - microbiology; Mouth Mucosa - pathology; Peptides - pharmacology; Pharmacology. Drug treatments; Protegrin peptide; Proteins; Proteins - pharmacology; Proteins - therapeutic use; Pseudomonas; Saliva - microbiology; Staphylococcus aureus; Streptococcus; Streptococcus - drug effects; Streptococcus - physiology; Streptococcus mitis; Streptococcus salivarius; Streptococcus sanguis; Susceptibility; Human; Healthy subject; Peptides; Oral administration; Microflora; In vitro; Biological activity; Antimicrobial agent; Fungi; Prevention; Oral cavity; In vivo; Antibiotic; Antifungal agent; Chemotherapy; Sensitivity resistance; Bacteria; Oral cavity disease; Antibacterial agent; Thallophyta